| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| ANHEUSER-BUSCH INBEV WOR COMPA | 115,931 | 114,578 |
| BANK OF AMERICA CORP MEDIUM TE | 99,760 | 97,192 |
| CITIGROUP INC MEDIUM TERM NOTE | 99,880 | 98,683 |
| PMORGAN CHASE & CO MEDIUM TERM | 99,950 | 100,139 |
| SOUTHERN CAL EDISON 1ST MTG - | 98,955 | 97,583 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| AMERICAN CENTURY SMALL CAP VAL | 73,407 | 65,030 |
| AVANTIS EMERGING MKTS EQUITY | 72,779 | 74,093 |
| COHEN AND STEERS REALTY SHARES | 97,717 | 94,403 |
| EURONET WORLDWIDE INC | 50,052 | 25,877 |
| FIDELITY ADVISOR VALUE STRATEG | 118,538 | 112,900 |
| GOLDMAN SACHS INTL EQ INC FD I | 99,301 | 104,203 |
| INFINITY Q DIVERSIFIED ALPHA F | 14,396 | |
| NEUBERGER BERMAN SMALL CAP GRO | 58,568 | 55,449 |
| PRINCIPAL FDS, INC. MIDCAP FD | 114,998 | 105,892 |
| PRUDENTIAL JENNISON INTL OPPOR | 97,217 | 92,985 |
| ULTRAGENYX PHARMACEUTICAL INC | 49,936 | 14,490 |
| VANGUARD GROWTH ETF | 242,560 | 247,834 |
| VANGUARD VALUE ETF | 218,243 | 224,031 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Administrative Fees | 10,149 | 10,149 | ||
| Bank Charges | 75 | 75 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Investment Management Services | 10,831 | 10,831 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 990-PF Estimated Tax for 2025 | 700 | |||
| 990-PF Excise Tax for 2024 | 588 |